Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Virtual Far-sight Reading Device for Pre-myopia in Children

Official title: A Randomized Controlled Clinical Trial on the Efficacy and Safety of the Virtual Far-sight Reading Device for Myopia Intervention in Pre-myopic Children

Run by Shanghai Eye Disease Prevention and Treatment Center · NCT06995911 · Data updated 2026-11-12

A device-guided reading program is tested to see if it can slow or prevent myopia in kids with pre-myopia and if it's safe with daily use for up to 6 months.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment80 (estimated)
SponsorShanghai Eye Disease Prevention and Treatment Center
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJune 1, 2025
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedMay 26, 2026
Trial IDNCT06995911 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 with very mild refractive error consistent with pre-myopia and a family history of myopia.

Probably not a fit

Children without pre-myopia or with ocular or systemic conditions excluding them from participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a novel Virtual Far-sight Reading Device designed to simulate long-distance viewing during near-work to slow myopia progression in children aged 6–12 with pre-myopia. It uses a randomized, crossover design where participants switch between using the device and standard near-work after 90 days, with ophthalmic evaluations at baseline, day 90, and day 180. Outcomes focus on changes in refraction and eye health, along with safety and tolerability over time. Compliance, daily use, and potential eye discomfort are monitored, and free eye checkups are provided during the trial.

Why it matters

Potential benefit: If successful, the device could reduce the risk of myopia progression and offer a daily-friendly option to help at-risk children.

How similar studies have gone: Previous approaches using near-work modification and visual environment changes have shown mixed results; this study tests a novel device-based method with a crossover design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 6-12 years (inclusive), gender unrestricted.

  * Worse eye cycloplegic spherical equivalent refraction (SER): -0.5 D \< SER ≤ +0.75 D; Cylinder ≤ -1.5 D in both eyes; Interocular anisometropia ≤ 1.5 D ③ Visual acuity: Best-corrected visual acuity (BCVA) ≤ 0.1 logMAR in both eyes. ④ Family history: At least one parent with myopia.

    * Intraocular pressure (IOP): 10-21 mmHg in both eyes; Interocular IOP difference ≤ 5 mmHg

      ⑥ Compliance: Commitment to daily home use of the Far-Image Light Field Desk per protocol, immediate notification to investigators if unable to comply, and completion of scheduled follow-ups.

      ⑦ Informed consent: Signed assent form (minor) and written informed consent from legal guardian.

Exclusion Criteria:

* Ocular comorbidities affecting vision/refractive development: Marfan syndrome; Lens pathologies (e.g., cataracts); Glaucoma; retinal detachment; retinopathy of prematurity

  * Systemic diseases: Immune/CNS disorders; Down syndrome; Severe cardiopulmonary/hepatic/renal dysfunction; Uncontrolled asthma

    * Ocular abnormalities: Manifest strabismus; Binocular vision dysfunction; Pathological ocular changes or active ocular inflammation ④ Recent myopia interventions (within 3 months prior to screening): Orthokeratology; multifocal contact lenses; Functional spectacles, red-light therapy

      ⑤ Medications affecting efficacy evaluation (within 3 months): Anticholinergics (e.g., atropine, pirenzepine); Cholinergics (e.g., pilocarpine)

      ⑥ Participation in other clinical trials within 3 months.

      ⑦ Contraindications/allergies to cycloplegics or study-related medications.

      ⑧ Chronic psychiatric disorders or cognitive impairment.

      ⑨ Other conditions deemed unsuitable by investigators.

Where it's running

  • Shanghai Eye Disease Prevention and Treatment Center
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.